Annual low-dose CT (LDCT) scans for people at high risk for lung cancer have proved to reduce the chance of death from the disease by 20 percent. However, only about 5 percent of eligible people are being screened.
Annual low-dose CT (LDCT) scans for people at high risk for lung cancer have proved to reduce the chance of death from the disease by 20 percent. However, only about 5 percent of eligible people are being screened.
In Texas, a disproportionate number of people have non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH) and NASH cirrhosis. Combine these conditions with alcohol misuse, and you have a state with the highest rate of liver cancer in the nation.
Concurrent radiation therapy and chemotherapy, known as chemoradiation, is a common treatment for locally advanced cancers. Adding concurrent chemotherapy can improve the effectiveness of radiation therapy but can also enhance the appearance of toxic side effects. This means that some cancer patients, especially those with comorbidities or poor health status, are ineligible for concurrent chemoradiation. Researchers at Baylor Scott & White Research Institute (BSWRI) are contributing to critical clinical trials to improve the effectiveness of radiation therapy for cancer patients, including those who are not eligible for concurrent chemoradiation.